ONCOLENS - Key Persons

Job Titles:

• Chief Executive Officer
• Co - Founder
• Member of the Board
• Member of the Leadership Team

Anju Mathew is CEO and co-founder of OncoLens. Most recently, she was the head of technology and innovation at McKesson's Medical Surgical business unit where she led the development and launch of several successful tools and business partnerships. Prior to her role at McKesson Medical Surgical, Anju was part of McKesson's corporate strategy group. She was also co-founder and executive at LumaMed, a medical device company focused on cancer imaging. A serial entrepreneur, Anju has raised more than $8M in funding, won numerous accolades including Women 2.0 2009 and the TAG top innovator's award. She is very passionate about innovation and technology startups - is an active angel investor, a prior member of the Atlanta Technology Angels group and served as board member at technology startups. She has served in strategy and technology roles at various companies including Thomson Reuters, A. T. Kearney, IBM and i2 Technologies. Anju has an MBA from Northwestern University's Kellogg School of Management and Bachelor's in Industrial Engineering from the Indian Institute of Technology. In her free time, Anju enjoys spending time with her family, going on long walks, watching movies and traveling around the world. Anju Mathew is CEO and co-founder of OncoLens. Most recently, she was the head of technology and innovation at McKesson's Medical Surgical business unit where she led the development and launch of several successful tools and business partnerships. Prior to her role at McKesson Medical Surgical, Anju was part of McKesson's corporate strategy group. She was also co-founder and executive at LumaMed, a medical device company focused on cancer imaging. A serial entrepreneur, Anju has raised more than $8M in funding, won numerous accolades including Women 2.0 2009 and the TAG top innovator's award. She is very passionate about innovation and technology startups - is an active angel investor, a prior member of the Atlanta Technology Angels group and served as board member at technology startups. She has served in strategy and technology roles at various companies including Thomson Reuters, A. T. Kearney, IBM and i2 Technologies. Anju has an MBA from Northwestern University's Kellogg School of Management and Bachelor's in Industrial Engineering from the Indian Institute of Technology. In her free time, Anju enjoys spending time with her family, going on long walks, watching movies and traveling around the world.

Job Titles:

• Member of the Board
• Member of the Leadership Team
• CEO for Martin Ventures

Devin Carty has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of the Congo, and pursued healthcare solutions as an entrepreneur, venture capitalist, and healthcare system operator. Devin is the CEO for Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee and provides oversight for 25 portfolio companies. Devin's historical investments include AmericanWell (IPO), OneDrop (recapitalized by Bayer), Valify (acquired by HCA Healthcare), Trilliant Health (recapitalized by Primus Capital), Jvion (acquired by JMI Equity), Avizia (acquired by AmericanWell), Healthcare Bluebook (acquired by Primus Capital), and Clockwise.MD (acquired by DocuTAP). Devin has cofounded several companies including Wellvana Health, Trilliant Health, and Clariture Health. For Wellvana, he serves as chairman of the board, recently transitioning from the role of CEO. For Trilliant Health, he served as chairman from its inception until the recapitalization with Primus Capital. Devin continues to serve as a board member for Trilliant, as well as for Ovia, Mployer Advisory, OncoLens and Hashed Health. For Clariture Health, as CEO, Devin led the company to increase monthly recurring revenue by 10x and delivered a contribution margin return on marketing investment to clients of 14x. Clariture merged with Aegis to form Trilliant. At Cancer Treatment Centers of America, Devin served as executive vice president, chief talent officer, and chief strategy officer. He led the enterprise growth strategy, and my team advanced the culture, increasing employee engagement to the 93 rd percentile, and enhanced patient experience, earning an NPS score of 96 and receiving a five-star rating from CMS. At Vanguard Health Systems, Devin was part of the senior leadership team that grew the organization to 29 hospitals, more than 46,000 employees, and over $6.5 billion in revenue. During his tenure, they completed an initial public offering in 2011 and the company's sale to Tenet for $4.3 billion in 2013. Devin's roles included corporate chief talent officer, chief experience officer, and chief marketing officer. At Gallup Consulting, Devin served as a partner for the healthcare division, consulting for some of the world's leading healthcare organizations-Cleveland Clinic, HCA, Trinity, Vanguard, and Henry Ford Health System. Devin Carty has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of the Congo, and pursued healthcare solutions as an entrepreneur, venture capitalist, and healthcare system operator. Devin is the CEO for Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee and provides oversight for 25 portfolio companies. Devin's historical investments include AmericanWell (IPO), OneDrop (recapitalized by Bayer), Valify (acquired by HCA Healthcare), Trilliant Health (recapitalized by Primus Capital), Jvion (acquired by JMI Equity), Avizia (acquired by AmericanWell), Healthcare Bluebook (acquired by Primus Capital), and Clockwise.MD (acquired by DocuTAP). Devin has cofounded several companies including Wellvana Health, Trilliant Health, and Clariture Health. For Wellvana, he serves as chairman of the board, recently transitioning from the role of CEO. For Trilliant Health, he served as chairman from its inception until the recapitalization with Primus Capital. Devin continues to serve as a board member for Trilliant, as well as for Ovia, Mployer Advisory, OncoLens and Hashed Health. For Clariture Health, as CEO, Devin led the company to increase monthly recurring revenue by 10x and delivered a contribution margin return on marketing investment to clients of 14x. Clariture merged with Aegis to form Trilliant. At Cancer Treatment Centers of America, Devin served as executive vice president, chief talent officer, and chief strategy officer. He led the enterprise growth strategy, and my team advanced the culture, increasing employee engagement to the 93 rd percentile, and enhanced patient experience, earning an NPS score of 96 and receiving a five-star rating from CMS. At Vanguard Health Systems, Devin was part of the senior leadership team that grew the organization to 29 hospitals, more than 46,000 employees, and over $6.5 billion in revenue. During his tenure, they completed an initial public offering in 2011 and the company's sale to Tenet for $4.3 billion in 2013. Devin's roles included corporate chief talent officer, chief experience officer, and chief marketing officer. At Gallup Consulting, Devin served as a partner for the healthcare division, consulting for some of the world's leading healthcare organizations-Cleveland Clinic, HCA, Trinity, Vanguard, and Henry Ford Health System.

Job Titles:

• VP of Operations and Customer Success

Ed is responsible for day to day operations of Oncolens, with a focus on ensuring successful customer onboarding and continued success in using our solution. Previous to this role, Ed held various client facing positions at Ingenious Med, a medical professional fee charge capture software solution company. As the VP of Implementations and Training, Ed played a key role in scaling the company through an explosive growth period. He also held positions as the VP of Specialty Solutions and Strategic Account Manager. Prior to working at Ingenious Med, Ed served in the United States Air Force where he was a C-130 pilot. He also served in various senior staff positions including at a US Embassy abroad and with the Space Shuttle Program. Ed has a Master's Degree in Management from Embry Riddle Aeronautical University and a Bachelor of Science from The United States Air Force Academy. He is a certified Project Management Professional and member of the Project Management Institute (PMI) and the American Health Information Management Association (AHIMA).

Job Titles:

• Nurse Navigators Present Results of Utilization of OncoLens to Streamline LDCT Screening Process at Oncology Nurse Navigator Conference, Austin TX

Emory Decatur Nurse Navigators present results of utilization of OncoLens to streamline LDCT screening process at Oncology Nurse Navigator Conference, Austin TX

Job Titles:

• Chief Operating Officer
• Leader
• Member of the Leadership Team

Serving in CEO, President, and COO roles, and with experience as a Board Director and Advisor, Heather is a leader with extensive strategic, commercial, and operational success driving growth in diverse enterprises, including startup, joint venture, privately-held and public companies. Before joining OncoLens, as the Principal of Health Acuity Consulting, she engaged in strategic and tactical projects in healthcare data, insights, and diagnostics. Her prior roles include; Chief Operating Officer at Lineagen, an independent, privately-held, genetics testing company for children with autism spectrum disorder, concurrent roles as President and Board Director for Eurofins Scientific's US Clinical Diagnostics Division at both EGL Genetics, a joint venture between Eurofins and Emory University, internationally recognized in rare and inherited disease genetic testing, and NTD, in the pre-natal screening market, President & CEO of CSI Laboratories, an independent, privately held national cancer diagnostics company, and Executive Vice President and Chief Operating Officer at Clarient, Inc., a NASDAQ traded, personalized medicine company. Heather serves as a Georgia Research Alliance Senior Advisor, and on advisory boards and committees with industry, non-profit, and government organizations. She received her B.A. with majors in Economics and Political Science from Duke University. In her free time, Heather is an avid golfer and loves coaching at the First Tee of Metro Atlanta. Serving in CEO, President, and COO roles, and with experience as a Board Director and Advisor, Heather is a leader with extensive strategic, commercial, and operational success driving growth in diverse enterprises, including startup, joint venture, privately-held and public companies. Before joining OncoLens, as the Principal of Health Acuity Consulting, she engaged in strategic and tactical projects in healthcare data, insights, and diagnostics. Her prior roles include; Chief Operating Officer at Lineagen, an independent, privately-held, genetics testing company for children with autism spectrum disorder, concurrent roles as President and Board Director for Eurofins Scientific's US Clinical Diagnostics Division at both EGL Genetics, a joint venture between Eurofins and Emory University, internationally recognized in rare and inherited disease genetic testing, and NTD, in the pre-natal screening market, President & CEO of CSI Laboratories, an independent, privately held national cancer diagnostics company, and Executive Vice President and Chief Operating Officer at Clarient, Inc., a NASDAQ traded, personalized medicine company. Heather serves as a Georgia Research Alliance Senior Advisor, and on advisory boards and committees with industry, non-profit, and government organizations. She received her B.A. with majors in Economics and Political Science from Duke University. In her free time, Heather is an avid golfer and loves coaching at the First Tee of Metro Atlanta.

Job Titles:

• Advisor
• Member of the Leadership Team
• Assistant Director at ATDC

Jane is Assistant Director at ATDC. Jane returned to ATDC as a Startup Catalyst, having started her career here many years ago. She then moved into venture capital and investment banking both in the United States and Europe before joining an early-stage, medical diagnostics company as chief financial officer. During her time there, she raised $60 million and completed eight international acquisitions. The company was listed on both the London and Oslo stock exchanges. Jane then worked with two venture-backed companies. She joined the founders of an online travel company as CEO, and took it from startup to the world's second-largest hotel booking site before Travelocity acquired it. At the request of her venture investors, Jane then joined a computer games developer as CEO and turned around the faltering enterprise before it was sold to a NASDAQ-listed games company. Most recently, Jane was CEO of an oncology-focused clinical research company, which grew from startup to a multinational firm with $15 million in annual revenue and offices across Europe and the United States. The company was financed through its own cash flow and was sold in early 2012 to a larger clinical research organization. Jane continues to work with fast growing companies - in interim and full-time positions - as a consultant, board member, and angel investor. In addition, Jane has served on boards for public and private companies, as well as government-related and non-profit organizations. She is a frequent speaker and panelist at conferences, companies, and universities and is an active volunteer in her community. Jane obtained her bachelor's degree from Wake Forest University and her master's degree at the Georgia Institute of Technology. Jane is Assistant Director at ATDC. Jane returned to ATDC as a Startup Catalyst, having started her career here many years ago. She then moved into venture capital and investment banking both in the United States and Europe before joining an early-stage, medical diagnostics company as chief financial officer. During her time there, she raised $60 million and completed eight international acquisitions. The company was listed on both the London and Oslo stock exchanges. Jane then worked with two venture-backed companies. She joined the founders of an online travel company as CEO, and took it from startup to the world's second-largest hotel booking site before Travelocity acquired it. At the request of her venture investors, Jane then joined a computer games developer as CEO and turned around the faltering enterprise before it was sold to a NASDAQ-listed games company. Most recently, Jane was CEO of an oncology-focused clinical research company, which grew from startup to a multinational firm with $15 million in annual revenue and offices across Europe and the United States. The company was financed through its own cash flow and was sold in early 2012 to a larger clinical research organization. Jane continues to work with fast growing companies - in interim and full-time positions - as a consultant, board member, and angel investor. In addition, Jane has served on boards for public and private companies, as well as government-related and non-profit organizations. She is a frequent speaker and panelist at conferences, companies, and universities and is an active volunteer in her community. Jane obtained her bachelor's degree from Wake Forest University and her master's degree at the Georgia Institute of Technology.

Job Titles:

• Advisor
• Member of the Leadership Team

Most recently, Kishore was Global head of Commercial Innovation for AstraZeneca's Oncology business unit. Prior to that he served as Principal, commercial head for a consultancy organization supporting several oncology focused Pharma organizations. Kishore is a serial entrepreneur & senior healthcare executive with over 2 decades experience across Top 20 Pharma organizations delivering meaningful impact to patients, businesses & customers. Kishore is a leader in commercial & medical innovation, a known disruptor to business models and recognized among the TOP 40 Healthcare Transformers in 2018. He has a proven track record of pushing the boundaries of commercial & medical teams to provide personalized care for patients, driving top line & bottom line growth for the business and providing an exceptional experience to the customers.

Job Titles:

• Chief Medical Officer
• Co - Founder
• Member of the Board
• Member of the Leadership Team

Lijo is a board certified Hematologist and Medical Oncologist with Atlanta Cancer Care and practices at DeKalb Medical Center and Southern Regional Medical Center in the Atlanta area. He has been named to the Atlanta Magazine's list of top doctors from 2013 to 2020.

Job Titles:

• Advisor

In his role, MG Granger required strong, value based relationships with major insurers to be affiliates. This required clear guidelines to assess and determine "best value". A rigorous process was implemented to ensure clear requirements and criteria to manage these relationships to measurable, accountable outcomes. He oversaw the acquisition, operation, and integration of TRICARE/DOD's managed care program within the Military Health System. MG Granger led a staff of 1,800 in planning, budgeting, and executing a $22.5 Billion Defense Health Program and in ensuring the effective and efficient provision of high-quality, accessible healthcare for 9.2 million Uniformed Service members, their families, retirees, and others located worldwide. Prior to joining TRICARE Management Activity, MG Granger led the largest U.S. and multi-national battlefield health system in our recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. He has led at every level of the Army Medical Department, with previous assignments as Commander, 44th Medical Command, XVIII Airborne Corps Command Surgeon and Director of Health Services, Fort Bragg, North Carolina, Commander, Europe Regional Medical Command, Director of TRICARE Europe, and the Command Surgeon, US Army Europe and 7th Army, Heidelberg, Germany, Acting Assistant Surgeon General for Force Projection, Commander, Landstuhl Army Regional Medical Center, Landstuhl, Germany and Commander, Ireland Army Community Hospital, Fort Knox, KY, and attended Army War College, Carlisle Barrack, PA. MG Granger has received numerous awards, decorations, and honors, including the Defense Superior Service Medal, the Legion of Merit with three oak leaf clusters, the Bronze Star Medal, and the Meritorious Service Medal with four oak leaf clusters. He is board-certified by the American Board of Internal Medicine and the Board of Hematology and Oncology, certified Physician Executive by the Certifying Commission in Medical Management, certified by the American College of Healthcare Executives, and Certified in Medical Quality by the American Board of Medical Quality. He is also certified in Cybersecurity Oversight from Carnegie Mellon University, certified in Healthcare Compliance by HCCA and is a certified Compliance Officer by AAPC. His professional affiliations include Member of the National Association of Health Services Executives, American Medical Association, the Interagency Institute for Federal Health Care Executives (Life Member) Governance Fellow, National Association of Corporate Directors, member and Fellow American College of Healthcare Executives, member and laureate American College of Physicians, member (life member) and fellow American Association for Physician Leadership, member and fellow American College of Medical Quality, Board of Directors, Defense Logistic Health, Cigna, Cerner, and Berg Health. Board of Trustee-Rosalind Franklin University, member of Arkansas State University Chancellor Cabinet, Meharry Medical College Institute of Computational Science and Data Analytics Advancement Council. He earned a Bachelor of Science degree from Arkansas State University in 1976, and a Doctor of Medicine degree from the University of Arkansas School of Medicine in 1980. MG Granger completed a residency in Internal Medicine in 1983 and a fellowship in Hematology-Oncology in 1986 at Fitzsimons Army Medical Center, Aurora, Colorado. MG Granger was awarded an honorary Doctor of Science Degree from Meharry Medical College in 2009.

Job Titles:

• President and CEO of the 5Ps, LLC

Major General Granger is currently the President and CEO of THE 5Ps, LLC, a health care, education, and leadership consulting organization, Centennial, CO since August 6, 2009. Prior to his retirement from the US Army on July 1, 2009, MG Granger served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs), Washington, DC, from December 2005 to May 2009. In this role, he was the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DOD health plan policy and performance.

Job Titles:

• Member of the Board
• Co - Founder and CEO of BIP Capital

Mark Buffington is co-founder and CEO of BIP Capital, a venture capital firm recognized as one of the most active and successful in the Southeast. In addition, he has co-founded three successful companies over the course of his career. Since founding BIP Capital, Mark has led investment rounds in more than 45 companies in a number of market verticals, including Healthcare IT, Digital Media, Ed Tech, Enterprise SaaS and FinTech. Notable exits include Vendormate, Ingenious Med, Shareholder InSite and Aspirion Health Resources. Mark serves on the board of directors of several companies, including the NFHS Network, AchieveIt, Excel Health, PlayOn! Sports, UserIQ and ConnexPay. He also serves on several nonprofit boards, including Buckhead Coalition, Inc. and the Georgia Tech College of Computing. Mark graduated from the Georgia Institute of Technology (where he lettered as a varsity baseball player) and also has an MBA from the A.B. Freeman School of Business at Tulane University. Mark Buffington is co-founder and CEO of BIP Capital, a venture capital firm recognized as one of the most active and successful in the Southeast. In addition, he has co-founded three successful companies over the course of his career. Since founding BIP Capital, Mark has led investment rounds in more than 45 companies in a number of market verticals, including Healthcare IT, Digital Media, Ed Tech, Enterprise SaaS and FinTech. Notable exits include Vendormate, Ingenious Med, Shareholder InSite and Aspirion Health Resources. Mark serves on the board of directors of several companies, including the NFHS Network, AchieveIt, Excel Health, PlayOn! Sports, UserIQ and ConnexPay. He also serves on several nonprofit boards, including Buckhead Coalition, Inc. and the Georgia Tech College of Computing. Mark graduated from the Georgia Institute of Technology (where he lettered as a varsity baseball player) and also has an MBA from the A.B. Freeman School of Business at Tulane University.

Job Titles:

• Member of the Leadership Team
• VP of Engineering

Robert's focus is a blend of building mission critical enterprise systems while growing and nurturing highly performing engineering teams in environments where failure is not an option. His background ranges from start-ups to Fortune 500 environments including development and exit of ExpressYard, a leading SaaS platform in the transportation sector now homed at GE Transportation / Wabtec and recently the rapid growth of teams and systems at Kabbage, Inc in the FinTech sector. He has a Bachelor of Science degree from University of Michigan and in his free time enjoys photography and spending time with his growing family. Robert's focus is a blend of building mission critical enterprise systems while growing and nurturing highly performing engineering teams in environments where failure is not an option. His background ranges from start-ups to Fortune 500 environments including development and exit of ExpressYard, a leading SaaS platform in the transportation sector now homed at GE Transportation / Wabtec and recently the rapid growth of teams and systems at Kabbage, Inc in the FinTech sector. He has a Bachelor of Science degree from University of Michigan and in his free time enjoys photography and spending time with his growing family.

Job Titles:

• Member of the Board
• Member of the Leadership Team

Shantanu is a veteran entrepreneur with a passion for Artificial Intelligence (AI) and patient wellness. His drive is fueled by a unique background that spans healthcare and the transformative AI technology that has changed the way complex problems are understood and solved today. Shantanu's career path started in the late 90s when he founded an AI company that was shifting search algorithms from keyword-based to intent driven through the use of Eigenspace. Shantanu moved into Accenture's Healthcare practice where he helped bring to market some of Accenture's most innovative and leading-edge offerings. Recently, Shantanu was Co-founder and CEO of Jvion from inception in 2011 to taking the company through a 9-figure acquisition by Private Equity in Jan 2019. Jvion, prior to being acquired became the nation's largest clinical AI product both in terms of number of hospitals served and number of patients impacted. Currently, Shantanu serves as Managing Partner of seedToB Capital, a VC fund specializing in and helping Healthcare AI companies path from seed stage to Series B. Shantanu earned his Bachelor of Engineering from the Indian Institute of Technology, India. Shantanu is a veteran entrepreneur with a passion for Artificial Intelligence (AI) and patient wellness. His drive is fueled by a unique background that spans healthcare and the transformative AI technology that has changed the way complex problems are understood and solved today. Shantanu's career path started in the late 90s when he founded an AI company that was shifting search algorithms from keyword-based to intent driven through the use of Eigenspace. Shantanu moved into Accenture's Healthcare practice where he helped bring to market some of Accenture's most innovative and leading-edge offerings. Recently, Shantanu was Co-founder and CEO of Jvion from inception in 2011 to taking the company through a 9-figure acquisition by Private Equity in Jan 2019. Jvion, prior to being acquired became the nation's largest clinical AI product both in terms of number of hospitals served and number of patients impacted. Currently, Shantanu serves as Managing Partner of seedToB Capital, a VC fund specializing in and helping Healthcare AI companies path from seed stage to Series B. Shantanu earned his Bachelor of Engineering from the Indian Institute of Technology, India.

Soon Anju began to collaborate with Dr. Lijo Simpson, a board-certified Hematologist/Oncologist and active participant in various cancer committees. Dr. Simpson understood first-hand the administrative burdens that a multidisciplinary approach to cancer care places on facilities. But he also understood the many advantages this approach brought to care teams and patients.

Job Titles:

• Advisor
• Chairman
• Member of the Leadership Team
• Medical Director, Markey Cancer Center Affiliate Network

Dr. Mullett, Medical Director, Markey Cancer Center Affiliate Network, is a surgical oncologist who specializes in the treatment of lung cancer. Although he began his career at the University of Kentucky as a cardiothoracic surgeon treating heart issues, he soon shifted his professional focus to treating lung cancer, one of the state's major health problems. Today, he is a co-leader and principal investigator of the Kentucky LEADS Collaborative to improve lung cancer survival. In addition to his work in lung cancer research, Dr. Mullett serves as the chair of UK's cancer committee and the medical director of the Markey Cancer Center Research Network, a collaborative network that conducts high priority trials including therapeutic oncology trials and interventional and non-interventional studies for community centers. Dr. Mullett currently serves as chair of the Commission on Cancer (CoC) of the American College of Surgeons (ACS). Dr. Mullett, Medical Director, Markey Cancer Center Affiliate Network, is a surgical oncologist who specializes in the treatment of lung cancer. Although he began his career at the University of Kentucky as a cardiothoracic surgeon treating heart issues, he soon shifted his professional focus to treating lung cancer, one of the state's major health problems. Today, he is a co-leader and principal investigator of the Kentucky LEADS Collaborative to improve lung cancer survival. In addition to his work in lung cancer research, Dr. Mullett serves as the chair of UK's cancer committee and the medical director of the Markey Cancer Center Research Network, a collaborative network that conducts high priority trials including therapeutic oncology trials and interventional and non-interventional studies for community centers. Dr. Mullett currently serves as chair of the Commission on Cancer (CoC) of the American College of Surgeons (ACS).